Indivior Pharmaceuticals Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: UDR Inc. Common Stock is far larger — about 2.6× Indivior Pharmaceuticals Inc. Common Stock's market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| INDV | UDR | |
|---|---|---|
Market Cap | $4.18B | $10.93B |
Volume | 1,819,746 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $41.83 | $41.24 |
52-Week Low | $24.09 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $16.96B |
Dividend Yield | — | 5.12% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →